-
Report details
-
12
Figures
-
6
Tables
-
Market Analysis
-
Overview of IVD Immunoassay
-
Market Outlook
-
Company Briefs
-
Abbott Diagnostics
-
Roche
-
Siemens Healthineers
-
Executive News Briefing
-
Briefs
-
OpGen Closes $3.38 Million in Direct Offering
-
Cue Health Appoints New CCO
-
Pleno Receives $40 million in Series A
-
Exact Sciences’ Revenues Supported by Screening Revenues
-
Sekisui Chemical Reports Double Digit Growth in All Business Segments During Q1…
-
Diagnostic Market Mergers, Acquisitions and Partnership Deals
-
Mergers and Acquisitions
-
Partnerships and Collaborations
-
Industry Watch
-
Region Watch
-
Italy
-
New Zealand
-
Singapore
-
Broad-based Company Announcements
-
Biocartis Commercializes HepatoPredict Test in Europe
-
Fujirebio Markets Self-Screening Cervical Cancer Test in Europe
-
Thermo Fisher Launches TaqPath Enteric Bacterial Select Panel
-
More Newsletters from Science and Medicine Group
|
In Vitro Diagnostics Business Outlook: Volume 2, Issue 1 - Immunoassay Overview
27 Oct 2022
A new twice-monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook offers the following:
• Market Sizing and Forecasting of IVD Market Segments in Every Issue
• Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About
• Industry Watch – Developments with COVID-19 and Other Testing
• M&A, Distribution, Partnerships Tracked and Charted
• New Product Introductions and Company Announcements
• Company Profiling and Quarterly Results Summaries
• Regional Market Coverage
Page Count: 47
Table of Contents
-
Market Analysis
-
Overview of IVD Immunoassay
-
Market Outlook
-
Company Briefs
-
Abbott Diagnostics
-
Roche
-
Siemens Healthineers
-
Executive News Briefing
-
Briefs
-
OpGen Closes $3.38 Million in Direct Offering
-
Cue Health Appoints New CCO
-
Pleno Receives $40 million in Series A
-
Exact Sciences’ Revenues Supported by Screening Revenues
-
Sekisui Chemical Reports Double Digit Growth in All Business Segments During Q1 FY22
-
Diagnostic Market Mergers, Acquisitions and Partnership Deals
-
Mergers and Acquisitions
-
Partnerships and Collaborations
-
Industry Watch
-
Region Watch
-
Italy
-
New Zealand
-
Singapore
-
Broad-based Company Announcements
-
Biocartis Commercializes HepatoPredict Test in Europe
-
Fujirebio Markets Self-Screening Cervical Cancer Test in Europe
-
Thermo Fisher Launches TaqPath Enteric Bacterial Select Panel
-
More Newsletters from Science and Medicine Group
|
More information about this product
Other Users Also Viewed
2 Aug 2022
This report, Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022, describes and discusses the global contract manufacturing markets, specifically focusing on the production of biotech (large molecule) products including extensiv…
|
